Metraipolis › archive › dc_4e1230aae59c

Early Pregnancy Treatment Decisions: Designing Perinatal Pharmacoepidemiology Studies using Real-World Data — arXiv:2608.11108

Source
arXiv (en)
Original
https://arxiv.org/abs/2608.11108
License (as archived)
CC0-1.0
Archived
2026-10-19T06:25:27.150Z
SHA-256 of the archived text
9df5f5a793dbe58594bc7b0f7043d720ac11a09c70d79702827a9bc1a9684220
Stable URL of this page
https://metraipolis.com/documento/dc_4e1230aae59c

How to cite

Early Pregnancy Treatment Decisions: Designing Perinatal Pharmacoepidemiology Studies using Real-World Data — arXiv:2608.11108 — arXiv (en), https://arxiv.org/abs/2608.11108 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_4e1230aae59c (Metraipolis archive dc_4e1230aae59c, sha256 9df5f5a793dbe58594bc7b0f7043d720ac11a09c70d79702827a9bc1a9684220)
BibTeX
@misc{dc4e1230aae59c,
  title = {Early Pregnancy Treatment Decisions: Designing Perinatal Pharmacoepidemiology Studies using Real-World Data — arXiv:2608.11108},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2608.11108},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_4e1230aae59c; sha256 9df5f5a793dbe58594bc7b0f7043d720ac11a09c70d79702827a9bc1a9684220},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.11108. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Research on the use of medications during pregnancy has two primary goals: to detect signals that medications may be harmful to a pregnant individual or fetus, and to support better treatment of pregnant people who require pharmacotherapy. Target trial emulation has been proposed as an approach to estimate the effects of interventions in real world data, with recent extensions to the pregnancy setting. This approach focuses on aligning eligibility and treatment initiation with start of follow up, which is particularly desirable given methodological challenges specific to pregnancy, such as right and left censoring and truncation, competing events, differences in gestational length, and varying etiologically susceptible periods. While previous work on target trial emulation in pregnancy has focused on initiation versus non-initiation of point treatments such as vaccines or antibiotics, this paper focuses on research questions regarding changes to pregestational treatment regimes, and aims to highlight opportunities and approaches to designing studies that align with relevant time points during early pregnancy at which treatment decisions occur in clinical practice. Using the example of treatment for type 2 diabetes mellitus, we review methods for identifying pregnancy episodes in routinely collected healthcare data, introduce possible time zero candidates, and discuss analytic approaches that minimize potential bias due to selection and immortal person time.

Tema degli esploratori: statistica e scienza dei dati (retro-catalogo arXiv: annunci del 2026-08-12 in stat.ME).
Categorie arXiv: Applications (stat.AP) ; Methodology (stat.ME).
Pagina del lavoro: https://arxiv.org/abs/2608.11108 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-19T06:16:10.999Z dalla pagina https://arxiv.org/catchup/stat.ME/2026-08-12?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).